Abbott Laboratories (ETR:ABL)
Germany
· Delayed Price · Currency is EUR 108.20
+1.60 (1.50%)
At close: Dec 5, 2025
Abbott Laboratories Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 186,961 | 189,494 | 172,877 | 179,118 | 212,232 | 153,363 | Upgrade
|
| Market Cap Growth | -2.55% | 9.61% | -3.48% | -15.60% | 38.39% | 12.04% | Upgrade
|
| Enterprise Value | 191,734 | 196,729 | 180,897 | 185,558 | 220,076 | 164,842 | Upgrade
|
| Last Close Price | 108.20 | 107.36 | 95.48 | 97.44 | 116.03 | 81.04 | Upgrade
|
| PE Ratio | 15.75 | 14.69 | 33.52 | 27.72 | 34.28 | 41.94 | Upgrade
|
| PS Ratio | 5.00 | 4.68 | 4.76 | 4.39 | 5.60 | 5.42 | Upgrade
|
| PB Ratio | 4.28 | 4.10 | 4.92 | 5.19 | 6.70 | 5.68 | Upgrade
|
| P/TBV Ratio | 10.26 | 10.96 | 31.28 | 55.76 | - | - | Upgrade
|
| P/FCF Ratio | 31.71 | 30.89 | 37.77 | 24.53 | 27.91 | 32.77 | Upgrade
|
| P/OCF Ratio | 24.06 | 22.92 | 26.32 | 19.98 | 22.92 | 23.74 | Upgrade
|
| EV/Sales Ratio | 5.09 | 4.86 | 4.99 | 4.54 | 5.81 | 5.83 | Upgrade
|
| EV/EBITDA Ratio | 18.41 | 19.01 | 19.11 | 16.02 | 19.64 | 22.94 | Upgrade
|
| EV/EBIT Ratio | 25.89 | 27.17 | 27.69 | 21.76 | 27.19 | 36.92 | Upgrade
|
| EV/FCF Ratio | 32.52 | 32.07 | 39.52 | 25.41 | 28.94 | 35.23 | Upgrade
|
| Debt / Equity Ratio | 0.25 | 0.32 | 0.41 | 0.49 | 0.53 | 0.60 | Upgrade
|
| Debt / EBITDA Ratio | 1.07 | 1.38 | 1.48 | 1.41 | 1.47 | 2.18 | Upgrade
|
| Debt / FCF Ratio | 1.88 | 2.41 | 3.16 | 2.30 | 2.23 | 3.48 | Upgrade
|
| Asset Turnover | 0.55 | 0.54 | 0.54 | 0.58 | 0.58 | 0.49 | Upgrade
|
| Inventory Turnover | 2.84 | 2.92 | 2.81 | 3.37 | 3.56 | 3.22 | Upgrade
|
| Quick Ratio | 1.09 | 1.05 | 1.00 | 1.06 | 1.28 | 1.14 | Upgrade
|
| Current Ratio | 1.70 | 1.67 | 1.64 | 1.63 | 1.85 | 1.72 | Upgrade
|
| Return on Equity (ROE) | 30.62% | 30.91% | 15.11% | 19.01% | 20.49% | 13.91% | Upgrade
|
| Return on Assets (ROA) | 6.79% | 6.06% | 6.11% | 7.61% | 7.79% | 4.86% | Upgrade
|
| Return on Capital (ROIC) | 9.03% | 7.94% | 8.23% | 10.34% | 10.64% | 6.61% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.40% | 11.10% | 12.20% | 15.50% | 14.80% | 9.00% | Upgrade
|
| Earnings Yield | 6.35% | 6.83% | 3.00% | 3.62% | 2.93% | 2.40% | Upgrade
|
| FCF Yield | 3.15% | 3.24% | 2.65% | 4.08% | 3.58% | 3.05% | Upgrade
|
| Dividend Yield | 1.95% | 2.02% | 1.97% | 1.84% | 1.38% | 1.54% | Upgrade
|
| Payout Ratio | 28.93% | 28.62% | 62.13% | 47.73% | 45.28% | 56.95% | Upgrade
|
| Buyback Yield / Dilution | 0.04% | 0.06% | 0.85% | 1.40% | -0.17% | -0.28% | Upgrade
|
| Total Shareholder Return | 1.99% | 2.07% | 2.82% | 3.24% | 1.21% | 1.26% | Upgrade
|
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.